We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb Defends FDA’s Approach to New Opioids After Dsuvia Approval
Gottlieb Defends FDA’s Approach to New Opioids After Dsuvia Approval
FDA Commissioner Scott Gottlieb defended the FDA’s approval of a powerful opioid that critics say is more addictive and susceptible to diversion than fentanyl — and said the agency plans to consider the merits of any new drug along with efforts to address the opioid epidemic.